Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery
Status:
Withdrawn
Trial end date:
2014-12-04
Target enrollment:
Participant gender:
Summary
This pilot clinical trial compares the imaging results of contrast-enhanced ultrasound to
contrast-enhanced magnetic resonance imaging (MRI) or computed tomography (CT), the current
clinical standard, in predicting treatment response in patients with kidney cancer undergoing
cryosurgery (a procedure in which an extremely cold liquid or an instrument called a
cryoprobe is used to freeze and destroy abnormal tissue). Using contrast-enhanced ultrasound
that does not involve a dye may help patients avoid side effects from a dye that is usually
used in MRI or CT and may help doctors measure blood flow and determine whether the
cryosurgery procedure treated the kidney tumor.
Phase:
Early Phase 1
Details
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University